Guided Therapeutics, Inc. (GTHP)
USD 0.08
(-0.12%)
USD 0.08
(-0.12%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -3.48 Million USD | 29.83% |
| 2022 | -4.97 Million USD | -33.4% |
| 2021 | -3.72 Million USD | -179.18% |
| 2020 | -1.33 Million USD | 60.51% |
| 2019 | -3.38 Million USD | -432.78% |
| 2018 | 1.01 Million USD | 109.5% |
| 2017 | -10.69 Million USD | -169.42% |
| 2016 | -3.97 Million USD | 42.48% |
| 2015 | -6.9 Million USD | 30.16% |
| 2014 | -9.88 Million USD | -36.98% |
| 2013 | -7.21 Million USD | -65.75% |
| 2012 | -4.35 Million USD | 34.48% |
| 2011 | -6.64 Million USD | -133.45% |
| 2010 | -2.84 Million USD | 54.19% |
| 2009 | -6.21 Million USD | -29.15% |
| 2008 | -4.81 Million USD | -259.48% |
| 2007 | 3.01 Million USD | 160.95% |
| 2006 | -4.94 Million USD | -139.03% |
| 2005 | -2.07 Million USD | 77.59% |
| 2004 | -9.23 Million USD | -253.85% |
| 2003 | -2.61 Million USD | 69.3% |
| 2002 | -8.5 Million USD | -22.09% |
| 2001 | -6.96 Million USD | -9.75% |
| 2000 | -6.34 Million USD | 3.83% |
| 1999 | -6.6 Million USD | 0.0% |
| 1998 | -6.6 Million USD | -15.79% |
| 1997 | -5.7 Million USD | -78.13% |
| 1996 | -3.2 Million USD | -370.59% |
| 1995 | -680 Thousand USD | 49.63% |
| 1994 | -1.35 Million USD | -10.66% |
| 1993 | -1.22 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -709 Thousand USD | -76.37% |
| 2024 Q1 | -402 Thousand USD | -4.15% |
| 2023 Q3 | -677 Thousand USD | 56.52% |
| 2023 FY | -3.48 Million USD | 29.83% |
| 2023 Q1 | -969 Thousand USD | 60.25% |
| 2023 Q4 | -386 Thousand USD | 42.98% |
| 2023 Q2 | -1.55 Million USD | -60.68% |
| 2022 FY | -4.97 Million USD | -33.4% |
| 2022 Q3 | -1.05 Million USD | -20.05% |
| 2022 Q2 | -878 Thousand USD | 16.78% |
| 2022 Q1 | -1.05 Million USD | -137.61% |
| 2022 Q4 | -2.43 Million USD | -131.31% |
| 2021 Q3 | 68 Thousand USD | 106.58% |
| 2021 Q1 | -517 Thousand USD | -124.4% |
| 2021 Q2 | -1.03 Million USD | -100.0% |
| 2021 Q4 | -444 Thousand USD | -752.94% |
| 2021 FY | -3.72 Million USD | -179.18% |
| 2020 Q1 | 2.71 Million USD | 150.78% |
| 2020 Q4 | 2.11 Million USD | 38.59% |
| 2020 Q2 | -6.74 Million USD | -348.49% |
| 2020 Q3 | 1.52 Million USD | 122.66% |
| 2020 FY | -1.33 Million USD | 60.51% |
| 2019 Q1 | -215 Thousand USD | 92.16% |
| 2019 Q3 | -126 Thousand USD | 95.27% |
| 2019 Q4 | 1.08 Million USD | 959.52% |
| 2019 Q2 | -2.66 Million USD | -1138.6% |
| 2019 FY | -3.38 Million USD | -432.78% |
| 2018 Q1 | 1.02 Million USD | 114.36% |
| 2018 Q4 | -2.74 Million USD | -267.56% |
| 2018 FY | 1.01 Million USD | 109.5% |
| 2018 Q2 | 3.37 Million USD | 228.92% |
| 2018 Q3 | -746 Thousand USD | -122.08% |
| 2017 Q4 | -7.15 Million USD | -202.37% |
| 2017 FY | -10.69 Million USD | -169.42% |
| 2017 Q1 | -107 Thousand USD | 94.68% |
| 2017 Q2 | -1.07 Million USD | -900.93% |
| 2017 Q3 | -2.36 Million USD | -120.82% |
| 2016 FY | -3.97 Million USD | 42.48% |
| 2016 Q1 | 130 Thousand USD | 107.39% |
| 2016 Q3 | -211 Thousand USD | 88.77% |
| 2016 Q4 | -2.01 Million USD | -852.61% |
| 2016 Q2 | -1.87 Million USD | -1545.38% |
| 2015 Q1 | -1.24 Million USD | 61.07% |
| 2015 FY | -6.9 Million USD | 30.16% |
| 2015 Q2 | -1.7 Million USD | -37.03% |
| 2015 Q3 | -2.19 Million USD | -28.43% |
| 2015 Q4 | -1.75 Million USD | 19.76% |
| 2014 FY | -9.88 Million USD | -36.98% |
| 2014 Q2 | -2.15 Million USD | -37.77% |
| 2014 Q1 | -1.56 Million USD | 29.42% |
| 2014 Q3 | -2.97 Million USD | -38.1% |
| 2014 Q4 | -3.19 Million USD | -7.6% |
| 2013 FY | -7.21 Million USD | -65.75% |
| 2013 Q4 | -2.21 Million USD | -53.89% |
| 2013 Q3 | -1.43 Million USD | 17.83% |
| 2013 Q2 | -1.75 Million USD | 3.58% |
| 2013 Q1 | -1.81 Million USD | -52.91% |
| 2012 Q1 | -1.01 Million USD | 63.31% |
| 2012 Q4 | -1.18 Million USD | -20.39% |
| 2012 Q3 | -986 Thousand USD | 15.51% |
| 2012 Q2 | -1.16 Million USD | -15.2% |
| 2012 FY | -4.35 Million USD | 34.48% |
| 2011 Q4 | -2.76 Million USD | -3.76% |
| 2011 Q2 | -496 Thousand USD | 31.68% |
| 2011 FY | -6.64 Million USD | -133.45% |
| 2011 Q3 | -2.66 Million USD | -436.49% |
| 2011 Q1 | -726 Thousand USD | -159.29% |
| 2010 Q3 | -635 Thousand USD | -13.6% |
| 2010 Q1 | -1.46 Million USD | -1.6% |
| 2010 FY | -2.84 Million USD | 54.19% |
| 2010 Q2 | -559 Thousand USD | 61.84% |
| 2010 Q4 | -280 Thousand USD | 55.91% |
| 2009 Q4 | -1.44 Million USD | 30.34% |
| 2009 FY | -6.21 Million USD | -29.15% |
| 2009 Q2 | -1.38 Million USD | -5.56% |
| 2009 Q3 | -2.07 Million USD | -49.35% |
| 2009 Q1 | -1.31 Million USD | -6.23% |
| 2008 Q2 | -1.2 Million USD | -53.77% |
| 2008 Q1 | -783 Thousand USD | 23.31% |
| 2008 FY | -4.81 Million USD | -259.48% |
| 2008 Q4 | -1.23 Million USD | 22.17% |
| 2008 Q3 | -1.58 Million USD | -31.89% |
| 2007 FY | 3.01 Million USD | 160.95% |
| 2007 Q4 | -1.02 Million USD | 20.23% |
| 2007 Q3 | -1.28 Million USD | -120.83% |
| 2007 Q2 | 6.14 Million USD | 633.97% |
| 2007 Q1 | -1.15 Million USD | -2.95% |
| 2006 Q3 | -1.1 Million USD | 27.81% |
| 2006 Q4 | -1.11 Million USD | -1.08% |
| 2006 Q2 | -1.53 Million USD | -28.52% |
| 2006 FY | -4.94 Million USD | -139.03% |
| 2006 Q1 | -1.19 Million USD | -182.09% |
| 2005 FY | -2.07 Million USD | 77.59% |
| 2005 Q1 | -1.24 Million USD | 62.2% |
| 2005 Q2 | -1.24 Million USD | -0.32% |
| 2005 Q3 | -1.09 Million USD | 12.27% |
| 2005 Q4 | 1.45 Million USD | 232.72% |
| 2004 FY | -9.23 Million USD | -253.85% |
| 2004 Q1 | -2.49 Million USD | -274.68% |
| 2004 Q2 | -1.75 Million USD | 29.71% |
| 2004 Q3 | -1.7 Million USD | 2.4% |
| 2004 Q4 | -3.28 Million USD | -92.39% |
| 2003 Q1 | -159 Thousand USD | 91.68% |
| 2003 FY | -2.61 Million USD | 69.3% |
| 2003 Q4 | 1.42 Million USD | 176.13% |
| 2003 Q3 | -1.87 Million USD | 9.87% |
| 2003 Q2 | -2.07 Million USD | -1206.92% |
| 2002 Q3 | -1.04 Million USD | 66.96% |
| 2002 FY | -8.5 Million USD | -22.09% |
| 2002 Q2 | -3.17 Million USD | -33.97% |
| 2002 Q1 | -2.37 Million USD | -33.97% |
| 2002 Q4 | -1.91 Million USD | -82.17% |
| 2001 FY | -6.96 Million USD | -9.75% |
| 2001 Q3 | -1.52 Million USD | -12.28% |
| 2001 Q2 | -1.36 Million USD | 41.13% |
| 2001 Q1 | -2.31 Million USD | -1205.08% |
| 2001 Q4 | -1.76 Million USD | -15.85% |
| 2000 Q1 | -1.67 Million USD | -39.25% |
| 2000 FY | -6.34 Million USD | 3.83% |
| 2000 Q4 | -177 Thousand USD | 92.45% |
| 2000 Q3 | -2.34 Million USD | -8.87% |
| 2000 Q2 | -2.15 Million USD | -28.9% |
| 1999 Q1 | -1.8 Million USD | -20.0% |
| 1999 Q3 | -1.1 Million USD | 56.0% |
| 1999 FY | -6.6 Million USD | 0.0% |
| 1999 Q4 | -1.2 Million USD | -9.09% |
| 1999 Q2 | -2.5 Million USD | -38.89% |
| 1998 FY | -6.6 Million USD | -15.79% |
| 1998 Q4 | -1.5 Million USD | -36.36% |
| 1998 Q3 | -1.1 Million USD | 45.0% |
| 1998 Q2 | -2 Million USD | 0.0% |
| 1998 Q1 | -2 Million USD | 0.0% |
| 1997 Q1 | -1.2 Million USD | -36.36% |
| 1997 FY | -5.7 Million USD | -78.13% |
| 1997 Q2 | -1.2 Million USD | 0.0% |
| 1997 Q3 | -1.3 Million USD | -8.33% |
| 1997 Q4 | -2 Million USD | -53.85% |
| 1996 FY | -3.2 Million USD | -370.59% |
| 1996 Q4 | -880 Thousand USD | 0.0% |
| 1996 Q3 | -880 Thousand USD | -17.33% |
| 1996 Q2 | -750 Thousand USD | -11.94% |
| 1996 Q1 | -670 Thousand USD | 0.0% |
| 1995 FY | -680 Thousand USD | 49.63% |
| 1994 FY | -1.35 Million USD | -10.66% |
| 1993 FY | -1.22 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | -722.81 Thousand USD | -382.698% |
| IR-Med Inc. | -4.9 Million USD | 28.926% |
| Polarean Imaging plc | -11.88 Million USD | 70.643% |
| Medical Supply International USA, Inc. | 394.84 Thousand USD | 983.649% |
| Avitar, Inc. | -2.25 Million USD | -54.406% |
| AVITA Medical, Inc. | -39.16 Million USD | 91.092% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | -199.485% |
| Össur hf. | 58.38 Million USD | 105.975% |
| Zecotek Photonics Inc. | -3.51 Million USD | 0.852% |
| QHSLab, Inc. | -468.36 Thousand USD | -644.937% |
| Wellstar International, Inc. | -3.1 Million USD | -12.242% |
| Össur hf. | 58.38 Million USD | 105.975% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 2.35 Million USD | 248.342% |
| Escalon Medical Corp. | -125.26 Thousand USD | -2685.384% |
| Aurora Spine Corporation | -1.68 Million USD | -107.609% |
| BrainsWay Ltd. | -4.19 Million USD | 16.869% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | -11.49 Million USD | 69.651% |
| Hamilton Thorne Ltd. | -607.02 Thousand USD | -474.773% |
| Vivos Inc. | -2.89 Million USD | -20.528% |
| MicroPort Scientific Corporation | -477.62 Million USD | 99.27% |
| Kelyniam Global, Inc. | -218.47 Thousand USD | -1497.008% |
| REMSleep Holdings, Inc. | -1.77 Million USD | -96.25% |
| CYduct Diagnostics, Inc. | -418.03 Thousand USD | -734.623% |
| Nanomix Corporation | -12.33 Million USD | 71.71% |
| Theraclion SA | -3.67 Million USD | 5.061% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -752.98 Thousand USD | -363.358% |
| Positron Corporation | -1.63 Million USD | -112.912% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -2.64 Million USD | -32.097% |
| Lombard Medical, Inc. | -31.03 Million USD | 88.758% |
| ALR Technologies Inc. | -11.89 Million USD | 70.672% |
| Stratec SE | 14.42 Million USD | 124.186% |
| Vycor Medical, Inc. | -69.69 Thousand USD | -4906.385% |
| Heart Tronics, Inc. | -13.32 Million USD | 73.82% |
| Nu-Med Plus, Inc. | -125.52 Thousand USD | -2679.504% |
| Perimeter Medical Imaging AI, Inc. | -14.03 Million USD | 75.142% |
| SANUWAVE Health, Inc. | -25.8 Million USD | 86.48% |
| VMS Rehab Systems, Inc. | 46.44 USD | 7513019.897% |
| Ingen Technologies, Inc. | -5.06 Million USD | 31.068% |
| Odyssey Group International, Inc. | -905.77 Thousand USD | -285.197% |
| United American Healthcare Corporation | 723 Thousand USD | 582.573% |
| ECGI Holdings, Inc. | -3.61 Million USD | 3.376% |
| Capital Group Holdings, Inc. | -658.02 Thousand USD | -430.224% |
| ADM Tronics Unlimited, Inc. | -716.85 Thousand USD | -386.712% |
| Urologix, Inc. | -7.6 Million USD | 54.14% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.69 Million USD | -105.986% |
| Nexeon MedSystems Inc. | -2.17 Million USD | -60.219% |
| SS Innovations International, Inc. | -20.94 Million USD | 83.34% |
| Qualis Innovations, Inc. | -805.02 Thousand USD | -333.405% |
| Smith & Nephew plc | 263 Million USD | 101.327% |
| NIOX Group Plc | 13.64 Million USD | 125.578% |
| Fuse Medical, Inc. | 1.45 Million USD | 338.978% |
| Broncus Holding Corporation | -28.09 Million USD | 87.58% |
| Brain Scientific Inc. | -12.34 Million USD | 71.735% |
| Pressure BioSciences, Inc. | -29.31 Million USD | 88.098% |
| Health Logic Interactive Inc. | -160.24 Thousand USD | -2077.25% |